The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Pretty poor take up on the retail offer I must say. I am astonished how little effort the brokers put into promoting it - looking to raise £500k and I saw no promotion whatsoever.
There was a buy order filled at 2.1p today, the highest in eleven months. If the new management are any good (which I've heard whispers they are) and they steer the good ship IGE back into profitability then this uptick might be the start of some fun.
Braveheart and especially Rise Step's involvement makes things even more interesting - after having a quiet word about the direction of the company and getting one of their men (Sunil Vadgama, someone with great x-ray commercialisation experience) on the board this will be a test of whether they've read the room correctly.
Does anyone know when results are due? The website says H1 prelim results are due April 2023 so hopefully we'll know a bit more in the next few weeks.
I thought that was a beautiful update. Confirmation that they've resolved their furnace issues, have ordered the kit to reach £50m annual capacity by September this year and are starting to look at growing their order book (including their pipeline growing by nearly £100m).
Once they officially achieve profitability and revenue growth really kicks in this is going to fly.
You know the old saying...win on Sunday, sell on Monday.
Aston Martin are currently the fastest manufacturer in F1! Very impressive.
I bet their new Sales Director wasn't expecting the markets to be this welcoming
I think awards are pretty useful when it comes to attracting customers actually. Even if it's just subliminally, it makes a positive difference on the persuasive journey. Plus it's arranged by a third party and it doesn't cost Haydale much (other than time) to apply for them.
I agree it's not the most exciting news but hey, it's good to see signs of work taking place - hopefully we see more over the coming months.
LongPositions, the main areas in which I'm expecting to see development are:
i) Thermal Fluids - they have a boron nitride solution which is used in radiators and reduces heating costs by 30%
ii) Elastomers - they've partnered with Vittoria who are focussing on graphene infused tyres
iii) Inks - their conductive inks are being utilised in various thermal applications (e.g. self heating garments, underfloor heating) as well as for medical devices such as tests for kidney disease and diabetes strips
iv) Ceramycguard - This is a surface treatment that reduces porosity of materials (e.g. concrete) and also increases durability to things like freeze/thaw cycles. I see this having significant appeal in the water industry, amongst others.
Finally, there is the HDPlas reactors themselves - I wouldn't be surprised to see them being sold in a few international markets over the next 12 months.
Hope that gives you some more insight.
Yes it is. I think at this point, the BOD turning up would constitute good news. Hopefully the fact they're holding it in Ammanford isn't lost on people either...
Cynicism aside, if anyone attends please let us know how it goes. I'd also be interested to know what is made of Ryan Howard, if he's there.
Considering AGM are about to run out of money and fundraises are looking increasingly likely at other nanomaterial companies, Haydale start to look more attractive with enough cash to see them through this challenging period.
I would guess the downward momentum is a result of the threat of a fundraise hanging over them.
Whilst the volume of trials they're announcing is very promising, from the outside it appears their finances are balanced on a knife edge - if they can get some sensorGROW/nuturGROW contracts over the line and/or generate enough business through the CEM division to see them through (both very likely IMHO) then they will rocket.
If they have to fundraise then it won't be pretty.
It looks like today's dip was caused by a very low volume sale so hopefully it's just MMs over-reacting rather than insider knowledge.
So Haydale have just put a post on LinkedIn stating that their CEO and UK Site Director attended the opening of a new Vittoria Park featuring, among other things, a 2,000m^2 high-tech tyre testing facility. I wonder if they were there just to try out some new tyres for their bike or if there's something more going on.
The combination of a steady Contract Electronic Manufacturing and pioneering Controlled Environmental Agriculture is dynamite - the symbiosis is quite beautiful and it's great to watch it start to pay dividends.
Did anyone here attend the General Meeting on Monday? If so, interested to know how it went down and what the mood was. Cheers in advance.
I notice that yesterday - presumably after the general meeting took place - there was a transaction of 12.5m shares @ 2.17p. Either someone was very ****ed off and decided to exit a large position or (more likely given the price) liked what they saw and took up a large position.
As predicted, the fundraising has completed and the money has been raised. Quilter subscribed for 33m shares and we'll find out who the other vultures are soon.
Haydale have now got a 12 month runway to shape up and start to present a far more hopeful vision of the future before markets lose patience.
Also, the book build will undoubtedly complete by tomorrow morning and be fully subscribed due to the aforementioned choreographing that's taken place over the last few weeks (as evidenced by the SP). My guess is a couple of IIs showed interest early on then changed their mind.
This has clearly been (very badly) choreographed by the Broker & IIs to walk the share price down to this level, and I suspect it will rise faster than would be expected.
Absolutely shocking display of disrespect to PIs here though - I'm seething.
Sadly there's bound to be a fundraise. Our best hope (and the most likely way to burn the shorts) is that they secure good terms and the SP recovers quickly once the business is properly capitalised.
re: price predictions...Come the morning bell, this is going to be a bloodbath. The insitutions who bought in at £3.35 are going to feel they've seriously overpaid.
Regarding H2 revenue, I presume payment for OEM8 will be booked in H2 which will account for the majority of the £10m. OEM8 is worth £100m between now and 2027 so roughly £10m per half is reasonable.